Nanoscope Therapeutics Press Releases
-
Nanoscope Therapeutics to Present at the 4th Annual Gene Therapy for Ophthalmic Disorders Summit
September 28, 2023 by Nanoscope Therapeutics
-
Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer
September 21, 2023 by Nanoscope Therapeutics
-
Nanoscope Therapeutics Unveils Clinical Trial Results for MCO-010 in Treating Stargardt Disease
August 9, 2023 by Nanoscope Therapeutics
-
Nanoscope Therapeutics to Present at the 2023 American Society of Retina Specialists (ASRS) Annual Scientific Meeting
July 21, 2023 by Nanoscope Therapeutics
Nanoscope Therapeutics In the News
- Retina Today : The Latest in Gene Therapy Clinical Trials for IRD
- Ophthalmology Times : ASRS 2023: The STARLIGHT Study
- Healio : Video: Early Data on Optogenetic Therapy in Stargardt Disease Promising
- Eye on the Cure Podcast Episode #46 : Aaron Osborne, MD, Chief Medical Officer and Chief Development Office of Nanoscope Therapeutics
- Clinical Trials Arena : Nanoscope reveals key efficacy data from Phase IIb ophthalmology trial